Incyte Corporation Appoints Suketu Upadhyay as Chief Financial Officer, Effective May 4, 2026

Published: 2026-04-28 08:35:55 ET INCY

Published on 04/28/2026 at 08:35 am EDT

Incyte Corporation announced the appointment of Suketu (Suky) Upadhyay as Chief Financial Officer (CFO) effective May 4, 2026. In his new role, Mr. Upadhyay will serve as a key member of the Executive Leadership Team and lead the company?s global finance organization responsible for Strategic Financial Planning; Capital Allocation; Investor Relations; Finance, Planning and Accounting; Global Sourcing; Environmental, Social, and Governance; Information Technology and Facilities. Suky will oversee all aspects of its finance function.

He will guide its capital allocation approach and apply effective financial stewardship in support of value creation for its shareholders. Mr. Upadhyay most recently served as Executive Vice President and Chief Financial Officer at Zimmer Biomet. Prior to that, he held senior finance leadership roles at several major pharmaceutical companies, including Senior Vice President of Global Financial Operations at Bristol Myers Squibb and Executive Vice President and Chief Financial Officer at Endo International.

Mr. Upadhyay also served as Interim Chief Financial Officer and Chief Accounting Officer at Becton Dickinson, and earlier in his career held global finance and business development roles at AstraZeneca and Johnson & Johnson. He holds a BS in Finance from Albright College and an MBA from The Fuqua School of Business at Duke University.